
674767100 | BLHC | 68481479 | | 9196390 | 5/19/2006 12:00:00 AM | S/P Rt TKR | | DIS | Admission Date: 10/2/2006 Report Status:
Discharge Date: 7/5/2006
****** FINAL DISCHARGE ORDERS ******
LIEBERMAN , THERON JEWELL 633-06-62-8
Donpool Ave. , West Tul Jo , Florida 39640
Service: ORT
DISCHARGE PATIENT ON: 3/6/06 AT 01:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: PUCKHABER , TRUMAN , M.D.
DISPOSITION: Rehabilitation
DISCHARGE MEDICATIONS:
TYLENOL ( ACETAMINOPHEN ) 650 MG PO Q4H
Starting Today ( 3/10 )
PRN Pain , Headache , Other:fever greater than
Instructions: Do not exceed 4000mg in 24 hours.
CALCIUM CARBONATE ( 500 MG ELEMENTAL CA++ )
500 MG PO DAILY
COLACE ( DOCUSATE SODIUM ) 100 MG PO BID
FAMOTIDINE 20 MG PO BID
INSULIN REGULAR HUMAN
Sliding Scale ( subcutaneously ) SC Q6H
If BS is less than 125 , then give 0 units subcutaneously
If BS is 125-150 , then give 2 units subcutaneously
If BS is 151-200 , then give 3 units subcutaneously
If BS is 201-250 , then give 4 units subcutaneously
If BS is 251-300 , then give 6 units subcutaneously
If BS is 301-350 , then give 8 units subcutaneously
If BS is 351-400 , then give 10 units subcutaneously and
call HO Call HO if BS is greater than 400
LEVOTHYROXINE SODIUM 50 MCG PO DAILY
Alert overridden: Override added on 8/23/06 by
SIMKULET , SONNY , M.D.
SERIOUS INTERACTION: WARFARIN & LEVOTHYROXINE SODIUM
Reason for override: will monitor
MVI ( MULTIVITAMINS ) 1 TAB PO DAILY
Override Notice: Override added on 8/23/06 by
BLACOCK , DEVIN , M.D.
on order for ZOCOR PO ( ref # 437553459 )
POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &
SIMVASTATIN Reason for override: will monitor
OXYCODONE 5 MG PO Q6H Starting Today ( 3/10 ) PRN Pain
HOLD IF: somnolent , mental status changes
COUMADIN ( WARFARIN SODIUM ) 6 MG PO x1
Instructions: Dose for 1/7/06. Monitor a daily PT/INR in
rehab and adjust the dose for a goal INR of
1.5-2.5;DVT prophylaxis is planned X 3 weeks
Food/Drug Interaction Instruction
No high Vitamin-K containing foods
Override Notice: Override added on 8/23/06 by
VERGIN , MERLIN , M.D.
on order for ZOCOR PO ( ref # 437553459 )
POTENTIALLY SERIOUS INTERACTION: WARFARIN & SIMVASTATIN
Reason for override: will monitor
Previous override information:
Override added on 8/23/06 by GUMZ , KENNITH , M.D.
on order for LEVOTHYROXINE SODIUM PO ( ref # 164534476 )
SERIOUS INTERACTION: WARFARIN & LEVOTHYROXINE SODIUM
Reason for override: will monitor
NORVASC ( AMLODIPINE ) 10 MG PO DAILY
Starting IN AM ( 3/9 ) HOLD IF: SBP < 110
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
METFORMIN 500 MG PO BID
Starting when TOLERATING ADA DIET
OXYCONTIN ( OXYCODONE CONTROLLED RELEASE ) 10 MG PO Q12H
HYZAAR ( 25 MG/100 MG ) ( HYDROCHLORTHIAZIDE 25M... )
1 TAB PO DAILY Starting IN AM ( 3/9 ) HOLD IF: SBP < 110
Number of Doses Required ( approximate ): 6
ACTOS ( PIOGLITAZONE ) 15 MG PO DAILY
Starting when TOLERATING ADA DIET
Food/Drug Interaction Instruction
May be taken without regard to meals
INSULIN NPH HUMAN 42 UNITS SC QAM HOLD IF: NPO
FERROUS SULFATE 325 MG PO TID
Food/Drug Interaction Instruction Avoid milk and antacid
DIET: House / Low chol/low sat. fat
ACTIVITY: weight bear as tolerated with UE support
FOLLOW UP APPOINTMENT( S ):
Dr Emore 4/27/06 Xray at 2:00pm Appt at 3:00pm 3/25/06 ,
Arrange INR to be drawn on 9/20/06 with f/u INR's to be drawn every
MONDAY/THURSDAY days. INR's will be followed by CMH Anticoagulation service , 316.629.1453
ALLERGY: LISINOPRIL
ADMIT DIAGNOSIS:
OA Rt Knee
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
S/P Rt TKR
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
Osteoarthritis , Hypertension , Diabuetes Mellitus , Hypothyroidism
OPERATIONS AND PROCEDURES:
8/23/06 CLIMES , SAM , M.D.
RT TKR
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
N/A
BRIEF RESUME OF HOSPITAL COURSE:
Pt underwent a Rt TKR on 6/20/06 for endstage OA. The patient tolerated
the procedure well , and had an uncomplicated post-operative course on the
TKR pathway with exception of post-op delerium which required a sitter
for safety on POD 2. Patients MS gradually improved , and returned to
baseline by POD 3 , at which time the sitter was discontinued. Pt was HD
stable with no transfusion requirements during her hospitalization. Hct
was trending up on POD 4 at 28.7. Standard care with PCEA for acute pain
management/CPM , prophylactic IV abx , and Coumadin/TEDS/P-boots for DVT
prophylaxis. Pt mobilized OOB with PT WBAT. Refer to the page 3 for
ROM/functional details. Wound clean and healing at time of discharge. Pt
stable for transfer to rehab on POD 4.
ADDITIONAL COMMENTS: DSD qd. The wound may be left OTA when dry. Staples may be removed in
rehab or by the VNA as of 2/30/06 , please sterristrip the wound. Continue
TEDS for DVT prophylaxis. When the patient is discharged home , please
arrange blood draws for PT/INR q Mon/Thurs with results called to the AHC
Anticoagulation Service uk349-114-7420 hgn 9 for outpatient
anticoagulation management. Goal INR is 1.5-2.5;DVT prophyalxis is planned
X 3 weeks. Any outpatient anticoagulation issues or action values should
be called to the Anticoagulation Service.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
Arrange blood draws for PT/INR q Mon/Thurs with results called to
583-443-9773 oxq 9 for outpatient anticoagulation management
NOTIFY the Anticoagulation Service when the patient is discharged home
Staple removal 7/27/06
Follow up with Dr Jantz as scheduled
No dictated summary
ENTERED BY: EARENFIGHT , LEOPOLDO , PA-C ( MT72 ) 3/6/06 @ 12
****** END OF DISCHARGE ORDERS ******